Share:
Share this content in WeChat
X
Review
Cognitive impairment in type 2 diabetes mellitus and its neuroimaging
YU Ying  SUN Qian  CUI Guang-bin 

DOI:10.12015/issn.1674-8034.2016.05.016.


[Abstract] Type 2 diabetes mellitus (T2DM), which is the independent risk factor of mild cognitive impairment, dementia, and stroke, affects the function of central nervous system significantly. Cognitive impairment may exist firstly. The study of its mechanism and early prevention plays an important role in the comprehensive treatment of diabetes. The mechanism is intricate involving vascular, nerve, function, etc. Functional magnetic resonance imaging explores the characteristics of diabetes cognitive impairment in various aspects. It combines the pathology and clinical presentation in order to make an early diagnosis and prevent the disease from progression. In this article, we present a review focusing on the mechanism of diabetes cognitive impairment and its neuroimaging.
[Keywords] Diabetes mellitus, type 2;Cognition disorders;Magnetic resonance imaging

YU Ying Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, China

SUN Qian Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, China

CUI Guang-bin* Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, China

*Correspondence to: Cui GB, E-mail: cgbtd@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  Financial support from the Natural Science Foundation of China No. 81471636
Received  2015-12-08
Accepted  2016-01-29
DOI: 10.12015/issn.1674-8034.2016.05.016
DOI:10.12015/issn.1674-8034.2016.05.016.

[1]
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke, 2011, 42(9): 2672-2713.
[2]
张倩,伍建林. 多模态功能MRI对糖尿病脑病的研究. 磁共振成像, 2015(1): 58-61.
[3]
Moulton CD, Stewart R, Amiel SA, et al. Factors associated with cognitive impairment in patients with newly diagnosed type 2 diabetes: a cross-sectional study. Aging Ment Health, 2015: 1-8.
[4]
Ma F, Wu T, Miao R, et al. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up. J Alzheimers Dis, 2015, 43(4): 1441-1449.
[5]
Xu W, Caracciolo B, Wang HX, et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes, 2010, 59(11): 2928-2935.
[6]
Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J, 2012, 42(5): 484-491.
[7]
Wang Y, Xu XY, Feng CH, et al. Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus. Metab Brain Dis, 2015, 30(4): 1027-1034.
[8]
刘长勤,Hoekstr J,熊康平, 等. 神经退行性疾病与2型糖尿病.转化医学研究(电子版), 2014, 4(2):8-15.
[9]
Bohnen NI, Kotagal V, Muller ML, et al. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord, 2014, 20(12): 1394-1398.
[10]
Luitse MJ, Biessels GJ, Rutten GE, et al. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol, 2012, 11(3): 261-271.
[11]
Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J, 2011, 75(5): 1042-1048.
[12]
Luchsinger JA. Type 2 Diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis, 2012, 30(Suppl 2): S185-S198.
[13]
Passaro A, Dalla Nora E, Morieri ML, et al. Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population. J Gerontol A Biol Sci Med Sci, 2015, 70(3): 294-302.
[14]
Rivera EJ, Goldin A, Fulmer N, et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis, 2005, 8(3): 247-268.
[15]
Rusinek H, Ha J, Yau PL, et al. Cerebral perfusion in insulin resistance and type 2 diabetes. J Cereb Blood Flow Metab, 2015, 35(1): 95-102.
[16]
Tiehuis AM, Vincken KL, van den Berg E, et al. Cerebral perfusion in relation to cognitive function and type 2 diabetes. Diabetologia, 2008, 51(7): 1321-1326.
[17]
Novak V, Zhao P, Manor B, et al. Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care, 2011, 34(11): 2438-2441.
[18]
Nagamachi S, Nishikawa T, Ono S, et al. Regional cerebral blood flow in diabetic patients: evaluation by N-isopropyl-123I-IMP with SPECT. Nucl Med Commun, 1994, 15(6): 455-460.
[19]
Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care, 2007, 30(5): 1193-1199.
[20]
Reijmer YD, Leemans A, Brundel M, et al. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes, 2013, 62(6): 2112-2115.
[21]
Mansur RB, Cha DS, Woldeyohannes HO, et al. Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship? Neuromolecular Med, 2014, 16(4): 658-668.
[22]
Falvey CM, Rosano C, Simonsick EM, et al. Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care, 2013, 36(3): 677-682.
[23]
Hsu JL, Chen YL, Leu JG, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage, 2012, 59(2): 1098-1105.
[24]
Yau PL, Kluger A, Borod JC, et al. Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus. J Clin Exp Neuropsychol, 2014, 36(1): 74-87.
[25]
Reijmer YD, Brundel M, de Bresser J, et al. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care, 2013, 36(1): 137-144.
[26]
Yau PL, Javier D, Tsui W, et al. Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res, 2009, 174(3): 223-230.
[27]
Zhang J, Wang Y, Wang J, et al. White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patients. Diabetes, 2014, 63(11): 3596-3605.
[28]
Lucatelli P, Montisci R, Sanfilippo R, et al. Is there an association between leukoaraiosis volume and diabetes? J Neuroradiol, 2015. [ DOI: ]
[29]
Zhang Y, Zhang X, Zhang J, et al. Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment. Neurosci Lett, 2014, 562: 1-6.
[30]
Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care, 2013, 36(12): 4036-4042.
[31]
Ajilore O, Narr K, Rosenthal J, et al. Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression. Psychiatry Res, 2010, 184(2): 63-70.
[32]
Gold SM, Dziobek I, Sweat V, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia, 2007, 50(4): 711-719.
[33]
Benedict C, Brooks SJ, Kullberg J, et al. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care, 2012, 35(3): 488-494.
[34]
Roberts RO, Knopman DS, Przybelski SA, et al. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology, 2014, 82(13): 1132-1141.
[35]
Cui Y, Jiao Y, Chen YC, et al. Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes, 2014, 63(2): 749-760.
[36]
Xia W, Wang S, Sun Z, et al. Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroen-docrinology, 2013, 38(11): 2493-2501.
[37]
刘代洪,段姗姗,张久权, 等. 2型糖尿病伴轻度认知功能障碍患者脑静息态功能MRI研究.磁共振成像, 2015, 6(3): 161-167, 171.
[38]
Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nat Protoc, 2006, 1(5): 2277-2281.
[39]
Chen Y, Liu Z, Zhang J, et al. Selectively disrupted functional connectivity networks in type 2 diabetes mellitus. Front Aging Neurosci, 2015, 7: 233.
[40]
Chen YC, Jiao Y, Cui Y, et al. Aberrant brain functional connectivity related to insulin resistance in type 2 diabetes: a resting-state fMRI study. Diabetes Care, 2014, 37(6): 1689-1696.
[41]
Cui Y, Jiao Y, Chen HJ, et al. Aberrant functional connectivity of default-mode network in type 2 diabetes patients. Eur Radiol, 2015, 25(11): 3238-3246.
[42]
Hoogenboom WS, Marder TJ, Flores VL, et al. Cerebral white matter integrity and resting-state functional connectivity in middle-aged patients with type 2 diabetes. Diabetes, 2014, 63(2): 728-738.

PREV The relevant research and latest developments of crossed cerebellar diaschisis
NEXT A fractional amplitude of low frequency fluctuation study of resting-state fMRI in stroke
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn